Cutaneous Oncology News

Researchers identified a gene signature that can predict which group of patients with melanoma will experience severe immune-related adverse events when treated with immune checkpoint inhibitor therapy, according to a study.

The FDA approved the novel immunotherapy denileukin diftitox-cxdl for treatment of certain patients with relapsed or refractory cutaneous T-cell lymphoma.

Dermatologic surgery wounds that were exposed to water in the hours following surgery did not experience an increase in infection, hematoma or bruising, according to a study.

Healio has compiled July’s most-read news in dermatology.

In this video, Hansa Bhargava, MD, and Victoria Barbosa, MD, MPH, MBA, FAAD, discuss the impact of UV rays on aging and the risk for skin cancer, as well as ways to protect your skin from the sun.

An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.

The American Skin Association has announced the recipients of its 2024 research grants for skin cancer and diseases, according to a press release.

Topically applied nanoparticle-encapsulated cannabidiol cream helped prevent and repair damage to the skin from ultraviolet A radiation, according to a first-of-its-kind study.

The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.

While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.